Assessment of the Predictors of Response to Glucagon in the Setting of Acute Esophageal Food Bolus Impaction
Tóm tắt
Esophageal food impactions are frequently seen in endoscopic practice. Glucagon is known to relax the lower esophageal sphincter and has been used with variable success to treat food impactions. We retrieved clinical information of all patients with acute food impactions who attended the emergency room from 1975 to 2000 from the Mayo diagnostic database. Data were abstracted on age, sex, body mass index, relevant prior medical history, food type ingested (meat, bread, vegetable, or other), duration of symptoms at presentation, dosage (in mg) of glucagon, outcome including success of glucagon or spontaneous passage, and endoscopic findings. A total of 222 cases of food impaction were identified, of whom 106 patients (48%) received glucagon, average 1 mg. In glucagon responders, meat was less likely to be the offending food type, accounting for 70% (glucagon responders) vs. 90% (in nonresponders) (p = 0.03), while responders were less likely to have esophageal rings/strictures detected on subsequent EGD compared with nonresponders, 0% (glucagon responders) vs. 31% (nonresponders) (p = 0.05). In the patients that did not receive glucagon, spontaneous resolvers had a shorter duration of symptoms at presentation, 3.3 h vs. 12.4 h (p = 0.07) and were less likely to have an organic esophageal obstruction detected on EGD, 0% vs. 21%. There were no significant differences between the resolvers and nonresolvers in terms of age, gender, BMI, and prior medical history. Conservative management of acute food bolus obstruction, either with or without glucagon, is most successful in the absence of a fixed esophageal obstruction. An impacted meat bolus is more likely to require intervention for removal than other food types. These clinical predictors should be considered before administration of glucagon.
Tài liệu tham khảo
GF Longstreth KJ Longstreth JF Yao (2001) ArticleTitleEsophageal food impaction: epidemiology and therapy. A retrospective, observational study. Gastrointest Endosc 53 IssueID2 193–198 Occurrence Handle10.1067/mge.2001.112709 Occurrence Handle1:STN:280:DC%2BD3Mzjslyjtg%3D%3D Occurrence Handle11174291
JT Ferrucci Jr JA Long Jr (1997) ArticleTitleRadiologic treatment of esophageal food impaction using intravenous glucagon. Radiology 125 IssueID1 25–28
K Hall–Boyer GP Zaloga B Chernow (1984) ArticleTitleGlucagon: hormone or therapeutic agent? Crit Care Med 12 IssueID7 584–589 Occurrence Handle1:STN:280:BiuB3svps1M%3D Occurrence Handle6375966
J Christiansen S Borgeskov (1974) ArticleTitleThe effect of glucagon and the combined effect of glucagon and secretin on lower esophageal sphincter pressure in man. Scand J Gastroenterol 9 IssueID7 615–618 Occurrence Handle1:CAS:528:DyaE2MXptlGrsg%3D%3D Occurrence Handle4428172
SS Jaffer GM Makhlouf BA Schorr AM Zfass (1974) ArticleTitleNature and kinetics of inhibition of lower esophageal sphincter pressure by glucagon. Gastroenterology 67 IssueID1 42–46 Occurrence Handle1:CAS:528:DyaE2cXltVSjs7Y%3D Occurrence Handle4834913
PJ Feczko AM Haggar RD Halpert (1985) ArticleTitleA reappraisal of upper gastrointestinal response to low-dose glucagon. Crit Rev Diagn Imaging 23 IssueID4 377–412 Occurrence Handle1:STN:280:BiqB2Mnjt1U%3D Occurrence Handle3893892
H Necheles J Sporn L Walker (1966) ArticleTitleEffect of glucagon on gastrointestinal motility. Am J Gastroenterol 45 IssueID1 34–39 Occurrence Handle1:CAS:528:DyaF28XmvFGjtg%3D%3D Occurrence Handle5902039
NG Kock N Darle G Dotevall (1967) ArticleTitleInhibition of intestinal motility in man by glucagon given intraportally. Gastroenterology 53 IssueID1 88–92 Occurrence Handle1:CAS:528:DyaF2sXksVanurg%3D Occurrence Handle6027233
AR Moosa AW Hall RG Hughes A Moraldi DE Moosa DB Skinner (1978) ArticleTitleEffect of gastrointestinal hormone infusions of lower oesophageal competence of rhesus monkeys. Br J Surg 65 IssueID7 499–504 Occurrence Handle1:STN:280:CSeB3M3itFA%3D Occurrence Handle96906
V Colon A Grade G Pulliam C Johnson R Fass (1999) ArticleTitleEffect of doses of glucagon used to treat food impaction on esophageal motor function of normal subjects. Dysphagia 14 IssueID1 27–30 Occurrence Handle1:STN:280:DyaK1M%2FkslCnug%3D%3D Occurrence Handle9828271
SW Trenkner DD Maglinte GA Lehman SM Chernish RE Miller CW Johnson (1983) ArticleTitleEsophageal food impaction: treatment with glucagon. Radiology 149 IssueID2 401–403 Occurrence Handle1:STN:280:BiuD3Mnmt1A%3D Occurrence Handle6622682
HW Marks RJ Lousteau (1979) ArticleTitleGlucagon and esophageal meat impaction. Arch Otolaryngol 105 IssueID6 367–368 Occurrence Handle1:STN:280:CSaB3cfotVA%3D Occurrence Handle454294
J Glauser GP Lilja B Greenfeld E Ruiz (1979) ArticleTitleIntravenous glucagon in the management of esophageal food obstruction. JACEP 8 IssueID6 228–231 Occurrence Handle1:STN:280:CSaC1MjksF0%3D Occurrence Handle449146
AN Reddy (1981) ArticleTitleNoninvasive management of esophageal meat impaction. Gastrointest Endosc 27 IssueID3 202–203 Occurrence Handle1:STN:280:Bi2D2M7isVA%3D
G Pillari S Bank I Katzka JD Fulco (1979) ArticleTitleMeat bolus impaction of the lower esophagus associated with a paraesophageal hernia. Successful noninvasive treatment with intravenous glucagon. Am J Gastroenterol 71 IssueID3 287–289 Occurrence Handle1:STN:280:CSaC1crgsFI%3D Occurrence Handle443232
BG Bryant DJ Trout (1982) ArticleTitleTreatment of esophageal food impaction—a new use for glucagon. Drug Intell Clin Pharm 16 IssueID5 407–409 Occurrence Handle1:STN:280:Bi2B3M%2FitFM%3D Occurrence Handle7084033
DJ Kaszar–Seibert WT Korn DJ Bindman MJ Shortsleeve (1990) ArticleTitleTreatment of acute esophageal food impaction with a combination of glucagon, effervescent agent, and water. AJR Am J Roentgenol 154 IssueID3 533–534
L Tibbling A Bjorkhoel E Jansson M Stenkvist (1995) ArticleTitleEffect of spasmolytic drugs on esophageal foreign bodies. Dysphagia 10 IssueID2 126–127 Occurrence Handle1:STN:280:ByqA38visFA%3D Occurrence Handle7600855
D Mehta M Attia E Quintana K Cronan (2001) ArticleTitleGlucagon use for esophageal coin dislodgment in children: a prospective, double-blind, placebo-controlled trial. Acad Emerg Med 8 IssueID2 200–203 Occurrence Handle1:STN:280:DC%2BD3M3gtlOmuw%3D%3D Occurrence Handle11157302